Chevy Chase Trust Holdings, Inc. Vertex Pharmaceuticals Inc Transaction History
Chevy Chase Trust Holdings, Inc.
- $30.7 Billion
- Q1 2025
A detailed history of Chevy Chase Trust Holdings, Inc. transactions in Vertex Pharmaceuticals Inc stock. As of the latest transaction made, Chevy Chase Trust Holdings, Inc. holds 443,048 shares of VRTX stock, worth $217 Million. This represents 0.7% of its overall portfolio holdings.
Number of Shares
443,048
Previous 444,701
0.37%
Holding current value
$217 Million
Previous $179 Million
19.94%
% of portfolio
0.7%
Previous 0.55%
Shares
32 transactions
Others Institutions Holding VRTX
# of Institutions
1,782Shares Held
224MCall Options Held
1.63MPut Options Held
1.47M-
Capital World Investors Los Angeles, CA28.3MShares$13.9 Billion1.8% of portfolio
-
Vanguard Group Inc Valley Forge, PA23.3MShares$11.4 Billion0.17% of portfolio
-
Black Rock Inc. New York, NY21.3MShares$10.5 Billion0.23% of portfolio
-
State Street Corp Boston, MA12MShares$5.88 Billion0.2% of portfolio
-
Capital Research Global Investors Los Angeles, CA10.4MShares$5.12 Billion0.9% of portfolio
About VERTEX PHARMACEUTICALS INC
- Ticker VRTX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 256,691,008
- Market Cap $126B
- Description
- Vertex Pharmaceuticals Incorporated, a biotechnology company, engages in developing and commercializing therapies for treating cystic fibrosis. The company markets SYMDEKO/SYMKEVI, ORKAMBI, and KALYDECO to treat patients with cystic fibrosis who have specific mutations in their cystic fibrosis transmembrane conductance regulator gene; and TRIKAF...